Cytalux

Active Ingredient(s): Pafolacianine Sodium
FDA Approved: * November 29, 2021
Pharm Company: * ON TARGET LABS
Category: Diagnostic Aid

Pafolacianine, sold under the brand name Cytalux, is an optical imaging agent.[1][2][3][4] The most common side effects of pafolacianine include infusion-related reactions, including nausea, vomiting, abdominal pain, flushing, dyspepsia, chest discomfort, itching and hypersensitivity.[2][3] It was approved for medical use in the United States in November 2021.[2][5] ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Cytalux 3.2 mg/1.6ml Intravenous Injection

NDC: 81052-138

Labeler:

On Target Laboratories, Inc.